CHEK1 and lung carcinoma: We also found that LY2603618 sensitivity did not correlate with CHK1 transcript levels, which is in agreement with Bryant et al. who found that CHK1 protein levels did not correlate with CHK1 inhibitor V158411 sensitivity in leukemia, lymphoma, and lung cancer cell lines [30].